Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement in Patients at Lower Surgical Risk: Meta-analysis of Randomized Trials
Canadian Journal of Cardiology · 2025
DOI: 10.1016/j.cjca.2025.02.036 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Tsahi T Lerman und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. E…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Aortic Valve, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The use of transcatheter aortic valve implantation (TAVI) for severe aortic stenosis is expanding to patients across the entire spectrum of surgical risk. We performed a meta-analysis and compared TAVI with surgical aortic valve replacement (SAVR) in trials that enrolled lower-risk patients. METHODS: We conducted a meta-analysis of randomized controlled trials and compared safety and efficacy outcomes between TAVI and SAVR among lower-risk patients (mean and/or median Society of Thoracic Surgeons [STS] score < 4). Point-estimate meta-analysis and reconstructed individual patient data survival analysis were conducted. Primary outcomes included all-cause mortality, stroke, and a composite of all-cause mortality or disabling stroke (PROSPERO, CRD42024541837). RESULTS: The analysis included 6 randomized controlled trials, totaling 2668 TAVI and 2573 SAVR patients, with a mean follow-up time of 3.02 years. TAVI was associated with lower risk of all-cause mortality (risk ratio, 0.68; 95% confidence interval, 0.52-0.88) and a composite of all-cause mortality or disabling stroke (risk ratio, 0.69; 95% confidence interval, 0.55-0.86) without a significant difference in stroke up to 2 years. Longer-term point-estimate analysis showed no difference. In reconstructed individual patient data, TAVI was associated with a lower risk of all-cause mortality, driven by an early advantage. Restricted mean survival time differences for primary outcomes were < 2.5 months and ≤ 1 month for all-cause mortality. TAVI was associated with a lower risk of bleeding, kidney injury, and atrial fibrillation, but a higher risk of pacemaker implantation and moderate to severe aortic regurgitation. CONCLUSIONS: In patients at lower surgical risk, TAVI was associated with improved short-term mortality. More data from long-term studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: tsahilerman@gmail.com.
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel; Department of Internal Medicine F-Recanati, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
- Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Cardiothoracic Surgery, The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Zitieren
APA
Lerman, T. T., Greenberg, N., Kheifets, M., Talmor-Barkan, Y., Codner, P., Perl, L., Witberg, G., Orvin, K., Eisen, A., Grinberg, T., Skalsky, K., Shapira, Y., Belkin, D., Jørgensen, T. H., Hørsted Thyregod, H. G., De Backer, O., Fishman, B., Kornowski, R., & Levi, A. (2025). Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement in Patients at Lower Surgical Risk: Meta-analysis of Randomized Trials. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.02.036
Vancouver
Lerman TT, Greenberg N, Kheifets M, Talmor-Barkan Y, Codner P, Perl L, et al. Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement in Patients at Lower Surgical Risk: Meta-analysis of Randomized Trials. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2025.02.036
BibTeX
@article{Lerman2025,
author = {Lerman, Tsahi T and Greenberg, Noam and Kheifets, Mark and Talmor-Barkan, Yeela and Codner, Pablo and Perl, Leor and Witberg, Guy and Orvin, Katia and Eisen, Alon and Grinberg, Tzlil and Skalsky, Keren and Shapira, Yaron and Belkin, David and Jørgensen, Troels Højsgaard and Hørsted Thyregod, Hans Gustav and De Backer, Ole and Fishman, Boris and Kornowski, Ran and Levi, Amos},
title = {Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement in Patients at Lower Surgical Risk: Meta-analysis of Randomized Trials},
journal = {Canadian Journal of Cardiology},
year = {2025},
doi = {10.1016/j.cjca.2025.02.036}
}
EUVIMED